Applications Filed on or After May 29, 2000; Grounds for Adjustment
FederalAgency guidance
Ask Donna
How this section applies to your facts.
USPTO MPEP › Chapter 2700 - Patent Terms, Adjustments, and Extensions › MPEP § 2730
Text
35 U.S.C. 154
Contents and term of patent; provisional rights.
*****
(b) ADJUSTMENT OF PATENT TERM.—
(1) PATENT TERM GUARANTEES.—
(A) GUARANTEE OF PROMPT PATENT AND TRADEMARK OFFICE
RESPONSES.— Subject to the limitations under paragraph (2), if the
issue of an original patent is delayed due to the failure of the
Patent and Trademark Office to—
(i) provide at least one of the notifications under
section 132
or a notice of allowance under
section
151
of this title not later than 14 months
after—
(I) the date on which an application was
filed under
section
111(a)
; or
(II) the date of commencement of the national
stage under
section
371
in an international
application;
(ii) respond to a reply under
section
132
, or to an appeal taken under
section 134
,
within 4 months after the date on which the reply was filed or
the appeal was taken;
(iii) act on an application within 4 months after the
date of a decision by the Patent Trial and Appeal Board under
section 134
or
135
or a
decision by a Federal court under
section
141
,
145
, or
146
in a
case in which allowable claims remain in the application; or
(iv) issue a patent within 4 months after the date
on which the issue fee was paid under
section
151
and all outstanding requirements were
satisfied,
the term of the patent shall be
extended 1 day for each day after the end of the period specified in
clause (i), (ii), (iii), or (iv), as the case may be, until the action
described in such clause is taken.
(B) GUARANTEE OF NO MORE THAN 3-YEAR APPLICATION
PENDENCY.— Subject to the limitations under paragraph (2), if the
issue of an original patent is delayed due to the failure of the
United States Patent and Trademark Office to issue a patent within
3 years after the actual filing date of the application under
section 111(a)
in
the United States, or, in the case of an international application,
the date of commencement of the national stage under
section
371
in the international application, not
including—
if the
issue of an original patent is delayed due to the failure of the
United States Patent and Trademark Office to issue a patent within
3 years after the actual filing date of the application under
section 111(a)
in
the United States, or, in the case of an international application,
the date of commencement of the national stage under
section
371
in the international application, not
including—
(i) any time consumed by continued examination of
the application requested by the applicant under
section
132(b)
;
(ii) any time consumed by a proceeding under
section
135(a)
, any time consumed by the
imposition of an order under
section 181
,
or any time consumed by appellate review by the Patent Trial and
Appeal Board or by a Federal court; or
(iii) any delay in the processing of the application
by the United States Patent and Trademark Office requested by
the applicant except as permitted by paragraph (3)(C),
the term of the patent shall be
extended 1 day for each day after the end of that 3-year period until
the patent is issued.
(C) GUARANTEE OF ADJUSTMENTS FOR DELAYS DUE TO DERIVATION
PROCEEDINGS, SECRECY ORDERS, AND APPEALS.— Subject to the limitations
under paragraph (2), if the issue of an original patent is delayed due
to—
(i) a proceeding under
section
135(a)
;
(ii) the imposition of an order under
section 181
;
or
(iii) appellate review by the Patent Trial and Appeal
Board or by a Federal court in a case in which the patent was
issued under a decision in the review reversing an adverse
determination of patentability, the term of the patent shall be
extended 1 day for each day of the pendency of the proceeding,
order, or review, as the case may be.
(a)
;
(ii) the imposition of an order under
section 181
;
or
(iii) appellate review by the Patent Trial and Appeal
Board or by a Federal court in a case in which the patent was
issued under a decision in the review reversing an adverse
determination of patentability, the term of the patent shall be
extended 1 day for each day of the pendency of the proceeding,
order, or review, as the case may be.
(2) LIMITATIONS.—
(A) IN GENERAL.— To the extent that periods of delay
attributable to grounds specified in paragraph (1) overlap, the period
of any adjustment granted under this subsection shall not exceed the
actual number of days the issuance of the patent was delayed.
(B) DISCLAIMED TERM.— No patent the term of which has
been disclaimed beyond a specified date may be adjusted under this
section beyond the expiration date specified in the disclaimer.
(C) REDUCTION OF PERIOD OF ADJUSTMENT.—
(i) The period of adjustment of the term of a
patent under paragraph (1) shall be reduced by a period equal to
the period of time during which the applicant failed to engage
in reasonable efforts to conclude prosecution of the
application.
(ii) With respect to adjustments to patent term made
under the authority of paragraph (1)(B), an applicant shall be
deemed to have failed to engage in reasonable efforts to
conclude processing or examination of an application for the
cumulative total of any periods of time in excess of 3 months
that are taken to respond to a notice from the Office making any
rejection, objection, argument, or other request, measuring such
3-month period from the date the notice was given or mailed to
the applicant.
(iii) The Director shall prescribe regulations
establishing the circumstances that constitute a failure of an
applicant to engage in reasonable efforts to conclude processing
or examination of an application.
o respond to a notice from the Office making any
rejection, objection, argument, or other request, measuring such
3-month period from the date the notice was given or mailed to
the applicant.
(iii) The Director shall prescribe regulations
establishing the circumstances that constitute a failure of an
applicant to engage in reasonable efforts to conclude processing
or examination of an application.
(3) PROCEDURES FOR PATENT TERM ADJUSTMENT DETERMINATION.—
(A) The Director shall prescribe regulations establishing
procedures for the application for and determination of patent term
adjustments under this subsection.
(B) Under the procedures established under subparagraph
(A), the Director shall—
(i) make a determination of the period of any
patent term adjustment under this subsection, and shall transmit
a notice of that determination no later than the date of
issuance of the patent; and
(ii) provide the applicant one opportunity to
request reconsideration of any patent term adjustment
determination made by the Director.
(C) The Director shall reinstate all or part of the
cumulative period of time of an adjustment under paragraph (2)(C) if
the applicant, prior to the issuance of the patent, makes a showing
that, in spite of all due care, the applicant was unable to respond
within the 3-month period, but in no case shall more than three
additional months for each such response beyond the original 3-month
period be reinstated.
(D) The Director shall proceed to grant the patent after
completion of the Director’s determination of a patent term adjustment
under the procedures established under this subsection,
notwithstanding any appeal taken by the applicant of such
determination.
3-month period, but in no case shall more than three
additional months for each such response beyond the original 3-month
period be reinstated.
(D) The Director shall proceed to grant the patent after
completion of the Director’s determination of a patent term adjustment
under the procedures established under this subsection,
notwithstanding any appeal taken by the applicant of such
determination.
(4) APPEAL OF PATENT TERM ADJUSTMENT DETERMINATION.—
(A) An applicant dissatisfied with the Director’s
decision on the applicant’s request for reconsideration under
paragraph (3)(B)(ii) shall have the exclusive remedy by a civil action
against the Director filed in the United States District Court for the
Eastern District of Virginia within 180 days after the date of the
Director’s decision on the applicant’s request for reconsideration.
Chapter 7 of title 5, United States Code, shall apply to such action.
Any final judgment resulting in a change to the period of adjustment
of the patent term shall be served on the Director, and the Director
shall thereafter alter the term of the patent to reflect such
change.
(B) The determination of a patent term adjustment under
this subsection shall not be subject to appeal or challenge by a third
party prior to the grant of the patent.
*****
I.
37 CFR 1.702 - GROUNDS FOR
ADJUSTMENT
[Editor Note: The provision of
37 CFR
1.702(a)(1)
, as reproduced below, was effective on April 1,
2013 and applies to patent applications granted on or after January 14,
2013.]
37 CFR 1.702 Grounds for adjustment of patent term due to examination delay under the
Patent Term Guarantee Act of 1999 (original applications, other than designs, filed
on or after May 29, 2000).
- GROUNDS FOR
ADJUSTMENT
[Editor Note: The provision of
37 CFR
1.702(a)(1)
, as reproduced below, was effective on April 1,
2013 and applies to patent applications granted on or after January 14,
2013.]
37 CFR 1.702 Grounds for adjustment of patent term due to examination delay under the
Patent Term Guarantee Act of 1999 (original applications, other than designs, filed
on or after May 29, 2000).
(a)
Failure to take certain actions within specified time
frames.
Subject to the provisions of
35 U.S.C. 154(b)
and this
subpart, the term of an original patent shall be adjusted if the issuance of
the patent was delayed due to the failure of the Office to:
(1) Mail at least one of a notification under
35
U.S.C. 132
or a notice of allowance under
35 U.S.C. 151
not later than fourteen months after
the date on which the application was filed under
35 U.S.C.
111(a)
or the date the national stage commenced
under
35 U.S.C. 371(b)
or
(f)
in an international application;
(2) Respond to a reply under
35 U.S.C.
132
or to an appeal taken under
35 U.S.C.
134
not later than four months after the date on
which the reply was filed or the appeal was taken;
(3) Act on an application not later than four months after
the date of a decision by the Patent Trial And Appeal Board under
35
U.S.C. 134
or
135
or a decision by
a Federal court under
35 U.S.C. 141
,
145
, or
146
where at least
one allowable claim remains in the application; or
(4) Issue a patent not later than four months after the date
on which the issue fee was paid under
35 U.S.C. 151
and all
outstanding requirements were satisfied.
(b)
Three-year pendency.
Subject to the provisions of
35 U.S.C. 154(b)
and this
subpart, the term of an original patent shall be adjusted if the issuance of
the patent was delayed due to the failure of the Office to issue a patent
within three years after the date on which the application was filed under
35 U.S.C.
111(a)
or the national stage commenced under
35 U.S.C.
371(b)
or
nts were satisfied.
(b)
Three-year pendency.
Subject to the provisions of
35 U.S.C. 154(b)
and this
subpart, the term of an original patent shall be adjusted if the issuance of
the patent was delayed due to the failure of the Office to issue a patent
within three years after the date on which the application was filed under
35 U.S.C.
111(a)
or the national stage commenced under
35 U.S.C.
371(b)
or
(f)
in an international
application, but not including:
(1) Any time consumed by continued examination of the
application under
35 U.S.C. 132(b)
;
(2) Any time consumed by an interference or derivation
proceeding under
35 U.S.C. 135(a)
;
(3) Any time consumed by the imposition of a secrecy order
under
35 U.S.C. 181
;
(4) Any time consumed by review by the Patent Trial and
Appeal Board or a Federal court; or
(5) Any delay in the processing of the application by the
Office that was requested by the applicant.
(c)
Delays caused by interference and derivation proceedings.
Subject to the provisions of
35 U.S.C. 154(b)
and this
subpart, the term of an original patent shall be adjusted if the issuance of
the patent was delayed due to interference or derivation proceedings under
35 U.S.C.
135(a)
.
(d)
Delays caused by secrecy order.
Subject to the provisions of
35 U.S.C.
154(b)
and this subpart, the term of an original patent
shall be adjusted if the issuance of the patent was delayed due to the
application being placed under a secrecy order under
35 U.S.C.
181
.
hall be adjusted if the issuance of
the patent was delayed due to interference or derivation proceedings under
35 U.S.C.
135(a)
.
(d)
Delays caused by secrecy order.
Subject to the provisions of
35 U.S.C.
154(b)
and this subpart, the term of an original patent
shall be adjusted if the issuance of the patent was delayed due to the
application being placed under a secrecy order under
35 U.S.C.
181
.
(e)
Delays caused by successful appellate review.
Subject to the
provisions of
35 U.S.C. 154(b)
and this subpart, the term of an
original patent shall be adjusted if the issuance of the patent was delayed due
to review by the Patent Trial and Appeal Board under
35 U.S.C.
134
or by a Federal court under
35 U.S.C.
141
or
145
, if the patent was
issued under a decision in the review reversing an adverse determination of
patentability. If an application is remanded by a panel of the Patent Trial and
Appeal Board and the remand is the last action by a panel of the Patent Trial
and Appeal Board prior to the mailing of a notice of allowance under
35 U.S.C.
151
in the application, the remand shall be considered a
decision by the Patent Trial and Appeal Board as that phrase is used in
35 U.S.C.
154(b)(1)(A)(iii)
, a decision in the review reversing an
adverse determination of patentability as that phrase is used in
35 U.S.C.
154(b)(1)(C)(iii)
, and a final decision in favor of the
applicant under
§ 1.703(e)
. A remand by a
panel of the Patent Trial and Appeal Board shall not be considered a decision
in the review reversing an adverse determination of patentability as provided
in this paragraph if there is filed a request for continued examination under
35 U.S.C.
132(b)
that was not first preceded by the mailing, after
such remand, of at least one of an action under
35 U.S.C.
132
or a notice of allowance under
35 U.S.C.
151
.
the Patent Trial and Appeal Board shall not be considered a decision
in the review reversing an adverse determination of patentability as provided
in this paragraph if there is filed a request for continued examination under
35 U.S.C.
132(b)
that was not first preceded by the mailing, after
such remand, of at least one of an action under
35 U.S.C.
132
or a notice of allowance under
35 U.S.C.
151
.
(f) The provisions of this section and
§§ 1.703
through
1.705
apply only to original applications, except
applications for a design patent, filed on or after May 29, 2000, and patents
issued on such applications.
35 U.S.C.
154(b)
, was amended effective May 29, 2000, and further amended by
Public Law 112-29, enacted on September 16, 2011, known as the Leahy-Smith America
Invents Act (AIA) and by Public Law 112-274, enacted on January 14, 2013, known as the
AIA Technical Corrections Act. All references to
35 U.S.C. 154(b)
hereinafter are to
35 U.S.C.
154(b)
, as amended effective May 29, 2000 and as further amended
by Public Laws 112-29 and 112-274.
37 CFR 1.702
-
1.705
implement the provisions of
35 U.S.C. 154(b)
and apply to
utility and plant patent applications filed on or after May 29, 2000.
Due to various effective dates of changes to the
provisions of
37 CFR 1.702
-
1.705
, there are several versions currently in place. For example,
there is a version of
37 CFR 1.702
that applies only to
patents granted on or after January 14, 2013 and another version that applies to patents
granted prior to January 14, 2013. For another example, there is a version of the
provisions of
37 CFR 1.703(b)(4)
and
rious effective dates of changes to the
provisions of
37 CFR 1.702
-
1.705
, there are several versions currently in place. For example,
there is a version of
37 CFR 1.702
that applies only to
patents granted on or after January 14, 2013 and another version that applies to patents
granted prior to January 14, 2013. For another example, there is a version of the
provisions of
37 CFR 1.703(b)(4)
and
(e)
that are only applicable to applications and patents in which
a notice of allowance issued on or after September 17, 2012. Office personnel need to
carefully consider the effective date provisions in the regulations in order to
determine which version to apply to the particular application or patent under
consideration.
37 CFR
1.702
sets forth the bases for patent term adjustment under
35 U.S.C.
154(b)(1)
.
37 CFR
1.702(a)
indicates that a patent is entitled to patent term
adjustment if the Office fails to perform certain acts of examination within specified
time frames (
35 U.S.C.
154(b)(1)(A)
).
Effective September 16, 2012, the Board of Patent Appeals
and Interferences has been redesignated the Patent Trial and Appeal Board. Accordingly,
37 CFR
1.702(a)(3)
has been amended to reflect the redesignation of the
patent appeal board.
For applications in which a patent was granted on or
after January 14, 2013,
37 CFR 1.702(a)(1)
provides patent
term adjustment if the Office fails to mail either a notification under
35 U.S.C.
132
or notice of allowance under
35 U.S.C. 151
not
later than 14 months after the date on which the application was filed under
35 U.S.C.
111(a)
or the date the national stage commenced under
35 U.S.C.
371(b)
or
pplications in which a patent was granted on or
after January 14, 2013,
37 CFR 1.702(a)(1)
provides patent
term adjustment if the Office fails to mail either a notification under
35 U.S.C.
132
or notice of allowance under
35 U.S.C. 151
not
later than 14 months after the date on which the application was filed under
35 U.S.C.
111(a)
or the date the national stage commenced under
35 U.S.C.
371(b)
or
(f)
in an international application.
For applications filed on or after May 29, 2000 in which the patent was granted prior to
January 14, 2013, the fourteen month measurement in international applications is based
upon the date that the application fulfilled the requirements of
35 U.S.C. 371
and
not the date the national stage commenced. See
37 CFR 1.702(a)(1)
(pre-2013-04-01)
.
37 CFR
1.702(b)
indicates that a patent is entitled to patent term
adjustment if, subject to a number of limitations, the Office fails to issue a patent
within three years of the actual filing date of the application (
35 U.S.C.
154(b)(1)(B)
). In the case of an international application, the
phrase “actual filing date of the application in the United States” means the date the
national stage commenced under
35 U.S.C. 371(b)
or
(f)
. See
Changes to Implement Patent Term Adjustment
Under Twenty-Year Patent Term,
65 FR 56366, 56382-84, (September 18, 2000),
1239 OG 14, 28-30 (October 3, 2000). On January 14, 2013, section 1(h)(1)(B) of the AIA
Technical Corrections Act amended
35 U.S.C
e
phrase “actual filing date of the application in the United States” means the date the
national stage commenced under
35 U.S.C. 371(b)
or
(f)
. See
Changes to Implement Patent Term Adjustment
Under Twenty-Year Patent Term,
65 FR 56366, 56382-84, (September 18, 2000),
1239 OG 14, 28-30 (October 3, 2000). On January 14, 2013, section 1(h)(1)(B) of the AIA
Technical Corrections Act amended
35 U.S.C. 154(b)(1)(B)
to change
“the actual filing date of the application in the United States” to “the actual filing
date of the application under
section 111(a)
in the United States,
or, in the case of an international application, the date of commencement of the
national stage under
section 371
in the international application.” The clarification
of the meaning of the phrase “actual filing date of the application in the United
States” did not require a change to the language of
37 CFR
1.702(b)
because the Office had interpreted, by regulation, the
language of the former 35 U.S.C. 154(b)(1)(B) to have the same meaning as the current
35 U.S.C.
154(b)(1)(B)
, as discussed above. See
Changes to
Implement Patent Term Adjustment Under Twenty-Year Patent Term,
65 FR
56366, 56382-84, (September 18, 2000), 1239 OG 14, 28-30 (October 3, 2000). See also
Revisions to Patent Term Adjustment,
78 FR 19416, 19417 (April 1,
2013), 1389 OG 224 (April 23, 2013).
Effective on September 16, 2012,
37 CFR
1.702(b)(2)
was amended to reflect the statutory change in section
3(i) of the AIA that replaced interference proceedings with derivation proceedings for
some applications. In addition, section 3(j) of the AIA redesignated the title “Board of
Patent Appeals and Interferences” as “Patent Trial and Appeal Board” in
35 U.S.C.
134
,
145
,
146
,
154
, and
305
. Accordingly,
37 CFR
1.702(b)(4)
was amended to reflect the redesignation of the title
of the Board. See
Changes to Implement Miscellaneous Post Patent Provisions of
the Leahy-Smith America Invents Act,
77 FR 46615 (August 6, 2012)
tion 3(j) of the AIA redesignated the title “Board of
Patent Appeals and Interferences” as “Patent Trial and Appeal Board” in
35 U.S.C.
134
,
145
,
146
,
154
, and
305
. Accordingly,
37 CFR
1.702(b)(4)
was amended to reflect the redesignation of the title
of the Board. See
Changes to Implement Miscellaneous Post Patent Provisions of
the Leahy-Smith America Invents Act,
77 FR 46615 (August 6, 2012).
37 CFR
1.702(c)
also indicates that a patent is entitled to patent term
adjustment if the issuance of the patent was delayed by an interference proceeding
(
35 U.S.C.
154(b)(1)(C)(i)
). Effective September 16, 2012,
37 CFR 1.702(c)
was amended to reflect the statutory change in section 3(i) of the AIA that replaced
interference proceedings with derivation proceedings for certain applications.
Specifically,
37 CFR 1.702(c)
added derivation
proceedings to the guarantees of adjustment for Office delays. In addition, section 3(j)
of the AIA redesignated the title “Board of Patent Appeals and Interferences” as “Patent
Trial and Appeal Board” in
35 U.S.C. 134
,
145
,
146
,
154
, and
305
.
37 CFR
1.702(d)
indicates that a patent is entitled to patent term
adjustment if the issuance of the patent was delayed by the application being placed
under a secrecy order under
35 U.S.C. 181
(
35 U.S.C.
154(b)(1)(C)(ii)
).
37 CFR 1.702(e)
indicates that a
patent is entitled to patent term adjustment if the issuance of the patent was delayed
by successful appellate review under
35 U.S.C. 134
,
141
, or
145
(
35 U.S.C. 154(b)(1)(C)(iii)
).
Effective May 24, 2004,
37 CFR 1.702(e)
was amended to
indicate that certain remands by the Board of Patent Appeals and Interferences shall be
considered “a decision in the review reversing an adverse determination of
patentability” for patent term adjustment purposes. Effective September 16, 2012,
37 CFR
1.702(e)
was amended to implemented section (3)(j) of the AIA by
redesignating the title “Board of Patent Appeals and Interferences” as “Patent Trial and
Appeal Board”
in remands by the Board of Patent Appeals and Interferences shall be
considered “a decision in the review reversing an adverse determination of
patentability” for patent term adjustment purposes. Effective September 16, 2012,
37 CFR
1.702(e)
was amended to implemented section (3)(j) of the AIA by
redesignating the title “Board of Patent Appeals and Interferences” as “Patent Trial and
Appeal Board”.
37 CFR
1.702(f)
provides that the provisions of
37 CFR 1.702
through
1.705
apply only to original (i.e., non-reissue) applications,
except applications for design patents, filed on or after May 29, 2000, and patents
issued on such applications. The term ‘‘original application’’ includes a continuing
application (continuation, divisional, or continuation-in-part, whether the application
is filed under
37
CFR 1.53(b)
or as a continued prosecution application under
37 CFR
1.53(d)
) and an international application under
35 U.S.C. 363
which has entered the national stage. See
Cooper Techs. Co. v. Dudas,
536 F.3d 1330, 87 USPQ2d 1705 (Fed. Cir. 2008). In particular, since a continued
prosecution application (CPA) filed under
37 CFR 1.53(d)
is a new (continuing)
application, a CPA filed on or after May 29, 2000, and before July 14, 2003, is entitled
to the benefits of the patent term adjustment provisions of
35 U.S.C. 154(b)
and
37 CFR
1.702
through
1.705
. Since a request for continued
examination (RCE) filed under
35 U.S.C. 132(b)
and
37 CFR
1.114
is
not
a new application (it is a submission in
a previously filed application), filing an RCE in an application filed before May 29,
2000, does
not
cause that application to be entitled to the benefits of the
patent term adjustment provisions of
35 U.S.C. 154(b)
and
37 CFR
1.702
through
1.705.
In regard to international
applications, such an application must have an international filing date on or after May
29, 2000 in order for the provisions of
37 CFR 1.702
through
1.705
to apply. The date on which an international application
fulfills the requirements of
35 U.S.C
o be entitled to the benefits of the
patent term adjustment provisions of
35 U.S.C. 154(b)
and
37 CFR
1.702
through
1.705.
In regard to international
applications, such an application must have an international filing date on or after May
29, 2000 in order for the provisions of
37 CFR 1.702
through
1.705
to apply. The date on which an international application
fulfills the requirements of
35 U.S.C. 371
(e.g., enters the
national stage) is not the filing date of the international application. See
35 U.S.C.
363
. The term “design patents” includes patents issued from design
applications filed under
35 U.S.C. 111
and international
design applications filed under
35 U.S.C. 385
.
II.
37 CFR 1.703 - PERIOD OF
ADJUSTMENT
[Editor Note:
37 CFR
1.703(a)(1)
, as reproduced below, includes amendments
applicable only to patents granted on or after January 14, 2013 and
37 CFR 1.703(b)(4)
and (e)
, as reproduced below, include amendments applicable
only to applications and patents in which a notice of allowance issued on or after
September 17, 2012. See
37 CFR 1.703 (2012-09-17 thru
2013-03-31)
or
37 CFR 1.703 (pre-2012-09-17)
for
paragraph (a)(1) applicable to patents granted before January 14, 2013. See
37
CFR 1.703 (pre-2012-09-17)
for paragraphs (b)(4) and (e) that
apply if the notice of allowance was issued before September 17, 2012.]
37 CFR 1.703 Period of adjustment of patent term due to examination delay.
(a) The period of adjustment under
§
1.702(a)
is the sum of the following periods:
(1) The number of days, if any, in the period beginning on
the day after the date that is fourteen months after the date on which
the application was filed under
35 U.S.C. 111(a)
the
date the national stage commenced under
35 U.S.C.
371(b)
or
7 CFR 1.703 Period of adjustment of patent term due to examination delay.
(a) The period of adjustment under
§
1.702(a)
is the sum of the following periods:
(1) The number of days, if any, in the period beginning on
the day after the date that is fourteen months after the date on which
the application was filed under
35 U.S.C. 111(a)
the
date the national stage commenced under
35 U.S.C.
371(b)
or
(f)
in an
international application and ending on the date of mailing of either an
action under
35 U.S.C. 132
, or a
notice of allowance under
35 U.S.C. 151
,
whichever occurs first;
(2) The number of days, if any, in the period beginning on
the day after the date that is four months after the date a reply under
§
1.111
was filed and ending on the date of mailing
of either an action under
35 U.S.C. 132
, or a
notice of allowance under
35 U.S.C. 151
,
whichever occurs first;
(3) The number of days, if any, in the period beginning on
the day after the date that is four months after the date a reply in
compliance with
§ 1.113(c)
was filed
and ending on the date of mailing of either an action under
35
U.S.C. 132
, or a notice of allowance under
35
U.S.C. 151
, whichever occurs first;
(4) The number of days, if any, in the period beginning on
the day after the date that is four months after the date an appeal brief
in compliance with
§ 41.37
was filed and
ending on the date of mailing of any of an examiner’s answer under
§
41.39
, an action under
35 U.S.C.
132
, or a notice of allowance under
35 U.S.C. 151
, whichever occurs first;
(5) The number of days, if any, in the period beginning on
the day after the date that is four months after the date of a final
decision by the Patent Trial and Appeal Board or by a Federal court in an
appeal under
35 U.S.C. 141
or a
civil action under
35 U.S.C. 145
or
146
where at least one allowable claim remains in
the application and ending on the date of mailing of either an action
under
35 U.S.C. 132
or a notice of allowance under
35
U.S.C. 151
, whichever occurs first; and
at is four months after the date of a final
decision by the Patent Trial and Appeal Board or by a Federal court in an
appeal under
35 U.S.C. 141
or a
civil action under
35 U.S.C. 145
or
146
where at least one allowable claim remains in
the application and ending on the date of mailing of either an action
under
35 U.S.C. 132
or a notice of allowance under
35
U.S.C. 151
, whichever occurs first; and
(6) The number of days, if any, in the period beginning on
the day after the date that is four months after the date the issue fee
was paid and all outstanding requirements were satisfied and ending on
the date a patent was issued.
(b) The period of adjustment under
§
1.702(b)
is the number of days, if any, in the period
beginning on the day after the date that is three years after the date on which
the application was filed under
35 U.S.C. 111(a)
or the
national stage commenced under
35 U.S.C. 371(b) or (f)
in
an international application and ending on the date a patent was issued, but
not including the sum of the following periods:
(1) The number of days, if any, in the period beginning on
the date on which any request for continued examination of the
application under
35 U.S.C. 132(b)
was
filed and ending on the date of mailing of the notice of allowance under
35
U.S.C. 151
;
(2)
(i) The number of days, if any, in the period
beginning on the date an interference or derivation proceeding was
instituted to involve the application in the interference or
derivation proceeding under
35
U.S.C. 135(a)
and ending on the date that the
interference or derivation proceeding was terminated with respect
to the application; and
(ii) The number of days, if any, in the period
beginning on the date prosecution in the application was suspended
by the Office due to interference or derivation proceedings under
35 U.S.C.
135(a)
not involving the application and
ending on the date of the termination of the suspension;
(3)
the date that the
interference or derivation proceeding was terminated with respect
to the application; and
(ii) The number of days, if any, in the period
beginning on the date prosecution in the application was suspended
by the Office due to interference or derivation proceedings under
35 U.S.C.
135(a)
not involving the application and
ending on the date of the termination of the suspension;
(3)
(i) The number of days, if any, the application was
maintained in a sealed condition under
35 U.S.C.
181
;
(ii) The number of days, if any, in the period
beginning on the date of mailing of an examiner's answer under
§ 41.39
in the
application under secrecy order and ending on the date the secrecy
order was removed;
(iii) The number of days, if any, in the period
beginning on the date applicant was notified that an interference
or derivation proceeding under
35
U.S.C. 135(a)
would be instituted but for the
secrecy order and ending on the date the secrecy order was removed;
and
(iv) The number of days, if any, in the period
beginning on the date of notification under
§
5.3(c)
of this chapter and ending on the date
of mailing of the notice of allowance under
35 U.S.C.
151
; and,
(4) The number of days, if any, in the period beginning on
the date on which jurisdiction over the application passes to the Patent
Trial and Appeal Board under
§ 41.35(a)
of this
chapter and ending on the date that jurisdiction by the Patent Trial and
Appeal Board ends under
§ 41.35(b)
of this
chapter or the date of the last decision by a Federal court in an appeal
under
35 U.S.C. 141
or
civil action under
35 U.S.C. 145
,
whichever is later.
beginning on
the date on which jurisdiction over the application passes to the Patent
Trial and Appeal Board under
§ 41.35(a)
of this
chapter and ending on the date that jurisdiction by the Patent Trial and
Appeal Board ends under
§ 41.35(b)
of this
chapter or the date of the last decision by a Federal court in an appeal
under
35 U.S.C. 141
or
civil action under
35 U.S.C. 145
,
whichever is later.
(c) The period of adjustment under
§
1.702(c)
is the sum of the following periods, to the
extent that the periods are not overlapping:
(1) The number of days, if any, in the period beginning on
the date an interference or derivation proceeding was instituted to
involve the application in the interference or derivation proceeding
under
35 U.S.C. 135(a)
and
ending on the date that the interference or derivation proceeding was
terminated with respect to the application; and
(2) The number of days, if any, in the period beginning on
the date prosecution in the application was suspended by the Office due
to interference or derivation proceedings under
35 U.S.C.
135(a)
not involving the application and ending on
the date of the termination of the suspension.
(d) The period of adjustment under
§
1.702(d)
is the sum of the following periods, to the
extent that the periods are not overlapping:
(1) The number of days, if any, the application was
maintained in a sealed condition under
35 U.S.C.
181
;
(2) The number of days, if any, in the period beginning on
the date of mailing of an examiner’s answer under
§
41.39
in the application under secrecy order and
ending on the date the secrecy order was removed;
(3) The number of days, if any, in the period beginning on
the date applicant was notified that an interference or derivation
proceeding under
35 U.S.C. 135(a)
would be instituted but for the secrecy order and ending on the date the
secrecy order was removed; and
iling of an examiner’s answer under
§
41.39
in the application under secrecy order and
ending on the date the secrecy order was removed;
(3) The number of days, if any, in the period beginning on
the date applicant was notified that an interference or derivation
proceeding under
35 U.S.C. 135(a)
would be instituted but for the secrecy order and ending on the date the
secrecy order was removed; and
(4) The number of days, if any, in the period beginning on
the date of notification under
§ 5.3(c)
of this
chapter and ending on the date of mailing of the notice of allowance
under
35 U.S.C. 151
.
(e) The period of adjustment under
§
1.702(e)
is the sum of the number of days, if any, in the
period beginning on the date on which jurisdiction over the application passes
to the Patent Trial and Appeal Board under
§
41.45(a)
of this chapter and ending on the date of a
final decision in favor of applicant by the Patent Trial and Appeal Board or a
Federal court in an appeal under
35 U.S.C. 141
or a civil
action under
35 U.S.C. 145
.
(f) The adjustment will run from the expiration date of the patent
as set forth in
35 U.S.C. 154(a)(2)
. To the
extent that periods of delay attributable to the grounds specified in
§
1.702
overlap, the period of adjustment granted under
this section shall not exceed the actual number of days the issuance of the
patent was delayed. The term of a patent entitled to adjustment under
§
1.702
and this section shall be adjusted for the sum of
the periods calculated under paragraphs (a) through (e) of this section, to the
extent that such periods are not overlapping, less the sum of the periods
calculated under
§ 1.704
. The date indicated
on any certificate of mailing or transmission under
§ 1.8
shall not be taken into account in this calculation.
nt entitled to adjustment under
§
1.702
and this section shall be adjusted for the sum of
the periods calculated under paragraphs (a) through (e) of this section, to the
extent that such periods are not overlapping, less the sum of the periods
calculated under
§ 1.704
. The date indicated
on any certificate of mailing or transmission under
§ 1.8
shall not be taken into account in this calculation.
(g) No patent, the term of which has been disclaimed beyond a
specified date, shall be adjusted under
§ 1.702
and this section
beyond the expiration date specified in the disclaimer.
37 CFR
1.703
specifies the period of adjustment if a patent is entitled
to patent term adjustment under
35 U.S.C. 154(b)(1)
and
37 CFR
1.702
. See
MPEP § 2731
for more information.
On September 16, 2012,
37 CFR
1.703
was amended to reflect the statutory change in section 3(i)
of the AIA that replaced interference proceedings with derivation proceedings for
certain applications. See AIA section 3(n).
37 CFR
1.702(c)
added derivation proceedings to the guarantees of
adjustment for Office delays. In addition, section 3(j) of the AIA redesignated the
“Board of Patent Appeals and Interferences” as “Patent Trial and Appeal Board” in
35 U.S.C.
134
,
145
,
146
,
154
, and
305
.
37 CFR
1.703(a)(5)
was amended to reflect the change to the title of the
Patent Board and
37 CFR 1.703(b)(2)
,
(b)(3)
,
(c)(1)
, and
(d)(3)
were amended to reflect the addition of derivation
proceedings to the rules providing patent term adjustment for Office delay.
Effective September 17, 2012, any application that
receives a notice of allowance on or after such date and issues as a patent, is entitled
to patent term adjustment under
37 CFR 1.702(e)
for the sum of the
number of days, if any, in the period beginning on the date on which jurisdiction passes
to the Patent Trial and Appeal Board and ends on the date of a final decision in favor
of applicant by the Patent Trial and Appeal Board or a federal court in an appeal under
35 U.S.C
ce on or after such date and issues as a patent, is entitled
to patent term adjustment under
37 CFR 1.702(e)
for the sum of the
number of days, if any, in the period beginning on the date on which jurisdiction passes
to the Patent Trial and Appeal Board and ends on the date of a final decision in favor
of applicant by the Patent Trial and Appeal Board or a federal court in an appeal under
35 U.S.C.
141
or a civil action under
35 U.S.C. 145
. See
Revisions of Patent Term Adjustment Provisions Relating to Appellate
Review,
77 FR 49354 (August 16, 2012).
Effective September 17, 2012, any application that
receives a notice of allowance on or after such date and issues as a patent, the three
year delay under
37 CFR 1.703(b)
does not include the
number of days, if any, in the period beginning on the date which jurisdiction passes to
the Patent Trial and Appeal Board under
37 CFR 41.35(a)
to the date that the
jurisdiction of the Patent Trial and Appeal Board ends under
37 CFR 41.35(b)
or
the date of the last decision by the federal court in an appeal under
35 U.S.C. 141
or civil action under
35 U.S.C. 145
.
The Office will also apply the changes to
37 CFR
1.703
in any timely patent term adjustment reconsideration
proceeding that is initiated on or after September 17, 2012. To allow patentees to take
advantage of changes to this provision relating to appellate review, the Office will
consider any of the following timely-filed proceedings to be an eligible "patent term
adjustment reconsideration proceeding" if initiated on or after September 17, 2012:
(1) reconsideration proceedings initiated pursuant to a
remand from a timely filed civil action in federal court;
(2) reconsideration proceedings initiated pursuant to a
timely request for reconsideration of the patent term adjustment indicated in the
patent under
37 CFR 1.705(d)
(2012) in
which the patentee argues that the change to
37 CFR
1.703
in this final rule is applicable to their patent;
and
) reconsideration proceedings initiated pursuant to a
remand from a timely filed civil action in federal court;
(2) reconsideration proceedings initiated pursuant to a
timely request for reconsideration of the patent term adjustment indicated in the
patent under
37 CFR 1.705(d)
(2012) in
which the patentee argues that the change to
37 CFR
1.703
in this final rule is applicable to their patent;
and
(3) reconsideration proceedings initiated pursuant to a
request for reconsideration that seeks reconsideration of the Office’s decision
under
37 CFR 1.705(d)
(2012)
regarding patent term adjustment under the Office’s former interpretation of the
appellate review language of
35 U.S.C. 154(b)(1)(B)(ii)
and
(C)(iii)
, if such request is filed within two months of the
date of the decision for which reconsideration is requested. See
37 CFR
1.181(f)
.
For applications in which the patent was granted on or
after January 14, 2013,
37 CFR 1.703(a)(1)
provides patent
term adjustment if the Office fails to mail at least one of a notification under
35 U.S.C.
132
or a notice of allowance under
35 U.S.C. 151
not
later than 14 months after the date on which the application was filed under
35 U.S.C.
111(a)
or the date the national stage commenced under
35 U.S.C.
371(b)
or
(f)
in an international application.
For applications filed on or after May 29, 2000 in which the patent was granted prior to
January 14, 2013, the fourteen month measurement in international applications is based
upon the date that application fulfilled the requirements of
35 U.S.C. 371
and
not the date the national stage commenced.
Effective January 9, 2015,
37 CFR
1.703(b)(1)
was amended to provide that the time consumed by
continued examination of the application under
35 U.S.C. 132(b)
is the number of
days, if any, in the period beginning on the date on which any request for continued
examination of the application under
35 U.S.C. 132(b)
was filed and
ending on the date of mailing of the notice of allowance under
35 U.S.C. 151
ive January 9, 2015,
37 CFR
1.703(b)(1)
was amended to provide that the time consumed by
continued examination of the application under
35 U.S.C. 132(b)
is the number of
days, if any, in the period beginning on the date on which any request for continued
examination of the application under
35 U.S.C. 132(b)
was filed and
ending on the date of mailing of the notice of allowance under
35 U.S.C. 151
.
This change is effective for any patent granted before, on, or after January 9, 2015.
See
MPEP §
2731
for more information. See also
Novartis AG v.
Lee,
740 F.3d 593, 109 USPQ2d 1385 (Fed. Cir. 2014).
III.
37 CFR 1.704 - REDUCTION OF
ADJUSTMENT
[Editor Note:
37 CFR
1.704(d)(3)
only applies for statements under
37 CFR
1.704(d)
filed on or after July 17, 2023.
37 CFR
1.704(c)(2)-(4), (c)(6), and (c)(9)-(10)
, as reproduced below,
include changes applicable only to original utility and plant patents issuing from
applications filed on or after May 29, 2000, in which a notice of allowance was
mailed on or after July 16, 2020. For 37 CFR 1.704(c)(2)-(4), (c)(6), and (c)(9)-(10)
in effect for applications filed on or after May 29, 2000, in which there was no
notice of allowance mailed on or after July 16, 2020, see 37 CFR 1.704 (2015‑03‑10
thru 2020‑07‑15).
37 CFR 1.704(c)(12)
, as
reproduced below, include changes applicable only to applications in which a request
for continued examination under
35 U.S.C. 132(b)
and
37 CFR
1.114
was filed on or after March 10, 2015. In addition,
37 CFR
1.704(c)(11)
,
(c)(13)
, and
May 29, 2000, in which there was no
notice of allowance mailed on or after July 16, 2020, see 37 CFR 1.704 (2015‑03‑10
thru 2020‑07‑15).
37 CFR 1.704(c)(12)
, as
reproduced below, include changes applicable only to applications in which a request
for continued examination under
35 U.S.C. 132(b)
and
37 CFR
1.114
was filed on or after March 10, 2015. In addition,
37 CFR
1.704(c)(11)
,
(c)(13)
, and
(c)(14)
, as reproduced below, include changes applicable only
to patent applications filed under
35 U.S.C. 111
on or after
December 18, 2013, and to international patent applications in which the national
stage commenced under
35 U.S.C. 371
on or after
December 18, 2013. For
37 CFR 1.704(c)(11) and (c)(12)
in effect for applications filed before (and international applications in which the
national stage commenced before) December 18, 2013, and in which a notice of appeal
was filed on or after September 17, 2012, see
37 CFR 1.704
(2012-09-17 thru 2013-12-17)
. For
37 CFR
1.704(c)(11)
in effect for applications in which there was no
notice of appeal filed on or after September 17, 2012, see
37 CFR 1.704
(pre-2012-09-17)
.
37 CFR
1.704(e)
below includes changes applicable only to applications
in which a notice of allowance was mailed on or after April 1, 2013. For 37 CFR
1.704(e) in effect for applications in which no notice of allowance was mailed on or
after April 1, 2013, see
37 CFR 1.704(e)
(pre-2013-03-31)
.]
37 CFR 1.704 Reduction of period of adjustment of patent term.
(a) The period of adjustment of the term of a patent under
§§ 1.703(a) through (e)
shall be reduced by a period
equal to the period of time during which the applicant failed to engage in
reasonable efforts to conclude prosecution (processing or examination) of the
application.
ter April 1, 2013, see
37 CFR 1.704(e)
(pre-2013-03-31)
.]
37 CFR 1.704 Reduction of period of adjustment of patent term.
(a) The period of adjustment of the term of a patent under
§§ 1.703(a) through (e)
shall be reduced by a period
equal to the period of time during which the applicant failed to engage in
reasonable efforts to conclude prosecution (processing or examination) of the
application.
(b) With respect to the grounds for adjustment set forth in
§§
1.702(a) through (e)
, and in particular the ground of
adjustment set forth in
§ 1.702(b)
, an applicant
shall be deemed to have failed to engage in reasonable efforts to conclude
processing or examination of an application for the cumulative total of any
periods of time in excess of three months that are taken to reply to any notice
or action by the Office making any rejection, objection, argument, or other
request, measuring such three-month period from the date the notice or action
was mailed or given to the applicant, in which case the period of adjustment
set forth in
§ 1.703
shall be reduced by the number of days, if any,
beginning on the day after the date that is three months after the date of
mailing or transmission of the Office communication notifying the applicant of
the rejection, objection, argument, or other request and ending on the date the
reply was filed. The period, or shortened statutory period, for reply that is
set in the Office action or notice has no effect on the three-month period set
forth in this paragraph.
e day after the date that is three months after the date of
mailing or transmission of the Office communication notifying the applicant of
the rejection, objection, argument, or other request and ending on the date the
reply was filed. The period, or shortened statutory period, for reply that is
set in the Office action or notice has no effect on the three-month period set
forth in this paragraph.
(c) Circumstances that constitute a failure of the applicant to
engage in reasonable efforts to conclude processing or examination of an
application also include the following circumstances, which will result in the
following reduction of the period of adjustment set forth in
§ 1.703
to the extent that the periods are not overlapping:
(1) Suspension of action under
§
1.103
at the applicant’s request, in which case the
period of adjustment set forth in
§ 1.703
shall be
reduced by the number of days, if any, beginning on the date a request
for suspension of action under
§ 1.103
was filed and
ending on the date of the termination of the suspension;
(2) Deferral of issuance of a patent under
§
1.314
, in which case the period of adjustment set
forth in
§ 1.703
shall be
reduced by the number of days, if any, beginning on the date a request
for deferral of issuance of a patent under
§
1.314
was filed and ending on the earlier of the
date a request to terminate the deferral was filed or the date the patent
was issued;
(3) Abandonment of the application or late payment of the
issue fee, in which case the period of adjustment set forth in
§
1.703
shall be reduced by the number of days, if
any, beginning on the date of abandonment or the day after the date the
issue fee was due and ending on the date the grantable petition to revive
the application or accept late payment of the issue fee was filed;
ent
was issued;
(3) Abandonment of the application or late payment of the
issue fee, in which case the period of adjustment set forth in
§
1.703
shall be reduced by the number of days, if
any, beginning on the date of abandonment or the day after the date the
issue fee was due and ending on the date the grantable petition to revive
the application or accept late payment of the issue fee was filed;
(4) Failure to file a petition to withdraw the holding of
abandonment or to revive an application within two months from the date
of mailing of a notice of abandonment, in which case the period of
adjustment set forth in
§ 1.703
shall be
reduced by the number of days, if any, beginning on the day after the
date two months from the date of mailing of a notice of abandonment and
ending on the date a petition to withdraw the holding of abandonment or
to revive the application was filed;
(5) Conversion of a provisional application under
35 U.S.C. 111(b)
to a nonprovisional application
under
35 U.S.C. 111(a)
pursuant to
35 U.S.C.
111(b)(5)
, in which case the period of adjustment
set forth in
§ 1.703
shall be
reduced by the number of days, if any, beginning on the date the
application was filed under
35 U.S.C. 111(b)
and
ending on the date a request in compliance with
§
1.53(c)(3)
to convert the provisional application
into a nonprovisional application was filed;
(6) Submission of a preliminary amendment or other
preliminary paper less than one month before the mailing of an Office
action under
35 U.S.C. 132
or
notice of allowance under
35 U.S.C. 151
that
requires the mailing of a supplemental Office action or notice of
allowance, in which case the period of adjustment set forth in
§
1.703
shall be reduced by the number of days, if
any, beginning on the day after the date that is eight months from either
the date on which the application was filed under
35 U.S.C.
111(a)
or the date of commencement of the national
stage under
35 U.S.C. 371(b) or
hat
requires the mailing of a supplemental Office action or notice of
allowance, in which case the period of adjustment set forth in
§
1.703
shall be reduced by the number of days, if
any, beginning on the day after the date that is eight months from either
the date on which the application was filed under
35 U.S.C.
111(a)
or the date of commencement of the national
stage under
35 U.S.C. 371(b) or
(f)
in an international application and ending on
the date the preliminary amendment or other preliminary paper was
filed;
(7) Submission of a reply having an omission
(
§
1.135(c)
), in which case the period of adjustment
set forth in
§ 1.703
shall be
reduced by the number of days, if any, beginning on the day after the
date the reply having an omission was filed and ending on the date that
the reply or other paper correcting the omission was filed;
(8) Submission of a supplemental reply or other paper, other
than a supplemental reply or other paper expressly requested by the
examiner, after a reply has been filed, in which case the period of
adjustment set forth in
§ 1.703
shall be
reduced by the number of days, if any, beginning on the day after the
date the initial reply was filed and ending on the date that the
supplemental reply or other such paper was filed;
(9) Submission of an amendment or other paper after a
decision by the Patent Trial and Appeal Board, other than a decision
designated as containing a new ground of rejection under
§
41.50(b)
of this title or statement under
§
41.50(c)
of this title, or a decision by a Federal
court, less than one month before the mailing of an Office action under
35
U.S.C. 132
or a notice of allowance under
35 U.S.C
) Submission of an amendment or other paper after a
decision by the Patent Trial and Appeal Board, other than a decision
designated as containing a new ground of rejection under
§
41.50(b)
of this title or statement under
§
41.50(c)
of this title, or a decision by a Federal
court, less than one month before the mailing of an Office action under
35
U.S.C. 132
or a notice of allowance under
35 U.S.C. 151
that requires the mailing of a
supplemental Office action or supplemental notice of allowance, in which
case the period of adjustment set forth in
§
1.703
shall be reduced by the number of days, if
any, beginning on the day after the date of the decision by the Patent
Trial and Appeal Board or by a Federal court and ending on date the
amendment or other paper was filed;
(10) Submission of an amendment under
§ 1.312
or other paper, other than an amendment
under
§
1.312
or other paper expressly requested by the
Office or a request for continued examination in compliance with
§
1.114
, after a notice of allowance has been given
or mailed, in which case the period of adjustment set forth in
§
1.703
shall be reduced by the number of days, if
any, beginning on the day after the date of mailing of the notice of
allowance under
35 U.S.C. 151
and
ending on the date the amendment under
§
1.312
or other paper was filed;
(11) Failure to file an appeal brief in
compliance with
§ 41.37
of this
chapter within three months from the date on which a notice of appeal to
the Patent Trial and Appeal Board was filed under
35 U.S.C.
134
and
§ 41.31
of this
chapter, in which case the period of adjustment set forth in
§ 1.703
shall be
reduced by the number of days, if any, beginning on the day after the
date three months from the date on which a notice of appeal to the Patent
Trial and Appeal Board was filed under
35 U.S.C.
134
and
§ 41.31
of this
chapter, and ending on the date an appeal brief in compliance with
§
41.37
of this chapter or a request for continued
examination in compliance with
§ 1.114
was
filed;
1.703
shall be
reduced by the number of days, if any, beginning on the day after the
date three months from the date on which a notice of appeal to the Patent
Trial and Appeal Board was filed under
35 U.S.C.
134
and
§ 41.31
of this
chapter, and ending on the date an appeal brief in compliance with
§
41.37
of this chapter or a request for continued
examination in compliance with
§ 1.114
was
filed;
(12) Submission of a request for continued
examination under
35 U.S.C. 132(b)
after any notice of allowance under
35 U.S.C. 151
has
been mailed, in which case the period of adjustment set forth in
§ 1.703
shall be
reduced by the number of days, if any, beginning on the day after the
date of mailing of the notice of allowance under
35 U.S.C.
151
and ending on the date the request for
continued examination under
35 U.S.C. 132(b)
was
filed;
(13) Failure to provide an application in
condition for examination as defined in paragraph (f) of this section
within eight months from either the date on which the application was
filed under
35 U.S.C. 111(a)
or
the date of commencement of the national stage under
35 U.S.C. 371(b) or
(f)
in an international application, in which case
the period of adjustment set forth in
§
1.703
shall be reduced by the number of days, if
any, beginning on the day after the date that is eight months from either
the date on which the application was filed under
35 U.S.C.
111(a)
or the date of commencement of the national
stage under
35 U.S.C. 371(b) or
(f)
in an international application and ending on
the date the application is in condition for examination as defined in
paragraph (f) of this section; and
(14) Further prosecution via a continuing application, in
which case the period of adjustment set forth in
§
1.703
shall not include any period that is prior to
the actual filing date of the application that resulted in the patent.
C. 371(b) or
(f)
in an international application and ending on
the date the application is in condition for examination as defined in
paragraph (f) of this section; and
(14) Further prosecution via a continuing application, in
which case the period of adjustment set forth in
§
1.703
shall not include any period that is prior to
the actual filing date of the application that resulted in the patent.
(d)
(1) A paper containing only an information
disclosure statement in compliance with
§§
1.97
and
1.98
will not be
considered a failure to engage in reasonable efforts to conclude
prosecution (processing or examination) of the application under
paragraphs (c)(6), (c)(8), (c)(9), or (c)(10) of this section, and a
request for continued examination in compliance with
§
1.114
with no submission other than an information
disclosure statement in compliance with
§§
1.97
and
1.98
will not be
considered a failure to engage in reasonable efforts to conclude
prosecution (processing or examination) of the application under
paragraph (c)(12) of this section, if the paper or request for continued
examination is accompanied by a statement that each item of information
contained in the information disclosure statement:
(i) Was first cited in any communication
from a patent office in a counterpart foreign or international
application or from the Office, and this communication was not
received by any individual designated in
§
1.56(c)
more than thirty days prior to the
filing of the information disclosure statement; or
(ii) Is a communication that was issued
by a patent office in a counterpart foreign or international
application or by the Office, and this communication was not
received by any individual designated in
§
1.56(c)
more than thirty days prior to the
filing of the information disclosure statement.
(2) The thirty-day period set forth in
paragraph (d)(1) of this section is not extendable.
statement; or
(ii) Is a communication that was issued
by a patent office in a counterpart foreign or international
application or by the Office, and this communication was not
received by any individual designated in
§
1.56(c)
more than thirty days prior to the
filing of the information disclosure statement.
(2) The thirty-day period set forth in
paragraph (d)(1) of this section is not extendable.
(3) The statement under paragraph (d)(1) of
this section must be submitted on the Office form (PTO/SB/133) provided
for such a patent term adjustment statement using the appropriate
document code (PTA.IDS). Otherwise, the paper or request for continued
examination will be treated as not accompanied by a statement under
paragraph (d)(1) of this section unless an application for patent term
adjustment, in compliance with
§
1.705(b)
, is filed, establishing that the paper or
request for continued examination was accompanied by a statement in
compliance with paragraph (d)(1) of this section. No changes to
statements on this Office form may be made. The presentation to the
Office (whether by signing, filing, submitting, or later advocating) of
this form, whether by a practitioner or non-practitioner, constitutes a
certification under
§ 11.18(b)
of this
chapter that the existing text and any certification statements on this
form have not been altered.
(e) The submission of a request under
§
1.705(c)
for reinstatement of reduced patent term
adjustment will not be considered a failure to engage in reasonable efforts to
conclude prosecution (processing or examination) of the application under
paragraph (c)(10) of this section.
der
§ 11.18(b)
of this
chapter that the existing text and any certification statements on this
form have not been altered.
(e) The submission of a request under
§
1.705(c)
for reinstatement of reduced patent term
adjustment will not be considered a failure to engage in reasonable efforts to
conclude prosecution (processing or examination) of the application under
paragraph (c)(10) of this section.
(f) An application filed under
35 U.S.C.
111(a)
is in condition for examination when it includes a
specification, including at least one claim and an abstract (§
1.72(b)
), and has papers in compliance with §
1.52
, drawings (if any) in compliance with §
1.84
, any English translation required by §
1.52(d)
or §
1.57(a)
, a “Sequence
Listing” in compliance with §§
1.821
through
1.825
(if applicable), a “Sequence Listing XML” in
compliance with §§
1.831
through
1.835
(if applicable), an inventor’s oath or declaration
or an application data sheet containing the information specified in §
1.63(b)
, the basic filing fee (§
1.16(a)
or
(c)
), the search fee (§
1.16(k)
or
(m)
), the examination fee (§
1.16(o)
or
(q)
), any certified copy of the previously filed
application required by §
1.57(a)
, and any
application size fee required by the Office under §
1.16(s)
.
An international application is in condition for examination when it has
entered the national stage as defined in §
1.491(b)
, and includes a specification, including at
least one claim and an abstract (§
1.72(b)
), and has papers in
compliance with §
1.52
, drawings (if any) in
compliance with §
1.84
, a “Sequence Listing”
in compliance with §§
1.821
through
1.825
(if applicable), a “Sequence Listing XML” in
compliance with §§
1.831
through
1.835
(if applicable), an inventor’s oath or declaration
or an application data sheet containing the information specified in §
1.63(b)
, the search fee (§
1.492(b)
), the examination fee (§
1.492(c)
), and any application size fee required by the
Office under §
1.492(j)
isting”
in compliance with §§
1.821
through
1.825
(if applicable), a “Sequence Listing XML” in
compliance with §§
1.831
through
1.835
(if applicable), an inventor’s oath or declaration
or an application data sheet containing the information specified in §
1.63(b)
, the search fee (§
1.492(b)
), the examination fee (§
1.492(c)
), and any application size fee required by the
Office under §
1.492(j)
. An application
shall be considered as having papers in compliance with §
1.52
,
drawings (if any) in compliance with §
1.84
, and a “Sequence
Listing” in compliance with §§
1.821
through
1.825
(if applicable), or a “Sequence Listing XML” in
compliance with §§
1.831
through
1.835
(if applicable), for purposes of this paragraph
(f) on the filing date of the latest reply (if any) correcting the papers,
drawings, “Sequence Listing,” or “Sequence Listing XML” that is prior to the
date of mailing of either an action under
35 U.S.C. 132
or a notice
of allowance under
35 U.S.C. 151
, whichever
occurs first.
Section 1.704 implements the provisions of
35 U.S.C.
154(b)(2)(C)
.
35 U.S.C. 154(b)(2)(C)
specifies
certain circumstances as constituting a failure of an applicant to engage in reasonable
efforts to conclude processing or examination of an application and also provides for
the Office to prescribe regulations establishing circumstances that constitute a failure
of an applicant to engage in reasonable efforts to conclude processing or examination of
an application. For more information, see
MPEP § 2732
.
Section 3(j) of the AIA redesignated the title “Board of
Patent Appeals and Interferences” as “Patent Trial and Appeal Board” in
35 U.S.C.
134
,
145
,
146
,
154
, and
305
. Effective September 16, 2012,
37 CFR
1.704(c)(9)
was amended to reflect the change to the title of the
Board
in reasonable efforts to conclude processing or examination of
an application. For more information, see
MPEP § 2732
.
Section 3(j) of the AIA redesignated the title “Board of
Patent Appeals and Interferences” as “Patent Trial and Appeal Board” in
35 U.S.C.
134
,
145
,
146
,
154
, and
305
. Effective September 16, 2012,
37 CFR
1.704(c)(9)
was amended to reflect the change to the title of the
Board.
Effective December 1, 2011,
37 CFR
1.704(d)
was amended to allow the diligent applicant to avoid
patent term adjustment reduction for an information disclosure statement (IDS)
submission that results from a communication from the Office if submitted within 30 days
of receipt of the communication by any individual designated in
37 CFR
1.56(c)
. See
Revision of Patent Term Adjustment Provisions
Relating to Information Disclosure Statements,
76 FR 74700 (December 1,
2011). Previously, this section only allowed a diligent applicant to avoid patent term
adjustment reduction if the IDS was cited as a result from a foreign patent Office.
Effective March 10, 2015,
37 CFR 1.704(d)(1)
provides that a
request for continued examination in compliance with
37 CFR 1.114
with no submission
other than an information disclosure statement in compliance with
37 CFR 1.97
and
37 CFR
1.98
will not be considered a failure to engage in reasonable
efforts to conclude prosecution (processing or examination) of the application under
37 CFR
1.704(c)(12)
, if the request for continued examination under
35 U.S.C.
132(b)
is accompanied by the statement provided for in
37 CFR
1.704(d)
.
37 CFR 1.704(d)
statements filed on
or after July 17, 2023, must be submitted on the Office form PTO/SB/133, “Patent Term
Adjustment Statement Under 37 CFR 1.704(d),” using the document code PTA.IDS. See
37 CFR
1.704(d)(3)
. For statements not submitted via the USPTO patent
electronic filing system, inclusion of the document code PTA.IDS on the form PTO/SB/133
satisfies the requirement to use the document code
d)
statements filed on
or after July 17, 2023, must be submitted on the Office form PTO/SB/133, “Patent Term
Adjustment Statement Under 37 CFR 1.704(d),” using the document code PTA.IDS. See
37 CFR
1.704(d)(3)
. For statements not submitted via the USPTO patent
electronic filing system, inclusion of the document code PTA.IDS on the form PTO/SB/133
satisfies the requirement to use the document code. Otherwise, the application will be
treated as if no
37 CFR 1.704(d)
statement had been
filed unless a request for reconsideration of the patent term adjustment, in compliance
with
37
CFR 1.705(b)
, is filed establishing that the IDS was accompanied
by a
37
CFR 1.704(d)
statement.
Effective September 17, 2012,
37 CFR
1.704(c)(11)
was amended to provide that failure to file an appeal
brief in compliance with
37 CFR 41.37
within three months
from the date that the notice of appeal was filed would constitute a failure to engage
in reasonable efforts to conclude processing or examination of the application. The
amended rule is applicable with respect to the filing of an appeal brief in any
application (other than design or reissue applications) in which the notice of appeal is
filed on or after September 17, 2012.
Prior to September 17, 2012,
37 CFR
1.704(c)(11)
contained a provision that further prosecution via a
continuing application is a circumstance constituting a failure of an applicant to
engage in reasonable efforts to conclude processing or examination of an application.
Effective September 17, 2012, this provision previously labeled as
37 CFR 1.704(c)(11)
was labelled
37 CFR 1.704(c)(12)
. Effective
December 18, 2013, this same provision was amended to be located in
37 CFR
1.704(c)(13)
, and a new provision regarding the failure to provide
an application in condition for examination, as defined in
37 CFR
1.704(f)
, was added as
37 CFR 1.704(c)(12)
. Effective March
10, 2015, the same provision formerly labelled as
37 CFR
1.704(c)(13)
is now labelled as
37 CFR
1.704(c)(14)
(c)(12)
. Effective
December 18, 2013, this same provision was amended to be located in
37 CFR
1.704(c)(13)
, and a new provision regarding the failure to provide
an application in condition for examination, as defined in
37 CFR
1.704(f)
, was added as
37 CFR 1.704(c)(12)
. Effective March
10, 2015, the same provision formerly labelled as
37 CFR
1.704(c)(13)
is now labelled as
37 CFR
1.704(c)(14)
.
Effective for applications filed under
35 U.S.C.
111
on or after December 18, 2013 and international applications
in which the national stage was commenced under
35 U.S.C. 371
on or after December
18, 2013, several changes to
37 CFR 1.704
were made.
37 CFR 1.704(c)(11)
was modified to
delete the “and” at the end of the paragraph because it is no longer the penultimate
paragraph of
37 CFR 1.704
. On December 18, 2013,
37 CFR
1.704(c)(12)
was added to provide for a reduction in any earned
patent term adjustment in the situation in which an application is not in condition for
examination within eight months from when an application under
35 U.S.C.
111
was filed or when an international application commenced the
national stage under
35 U.S.C. 371(b) or (f)
. Effective March 10, 2015, this provision
was amended to be labelled as
37 CFR 1.704(c)(13)
. On December 18,
2013,
37
CFR 1.704(f)
was added to define when an application is “in
condition for examination” for purposes of
37 CFR 1.704(c)(13)
.
37 CFR
1.704(f)
was amended in the final rule
Standard for
Presentation of Nucleotide and Amino Acid Sequence Listings Using eXtensible Markup
Language (XML) in Patent Applications To Implement WIPO Standard ST.26; Incorporation
by Reference,
87 FR 30806 (May 20, 2022) and this amendment is effective
for all applications filed before, on, or after July 1, 2022.
Effective for applications in which a request for continued
examination was filed on or after March 10, 2015,
37 CFR
1.704(c)(12)
was amended to include a new provision that
establishes the submission of a request for continued examination under
35 U.S.C
orporation
by Reference,
87 FR 30806 (May 20, 2022) and this amendment is effective
for all applications filed before, on, or after July 1, 2022.
Effective for applications in which a request for continued
examination was filed on or after March 10, 2015,
37 CFR
1.704(c)(12)
was amended to include a new provision that
establishes the submission of a request for continued examination under
35 U.S.C.
132(b)
after any notice of allowance under
35 U.S.C. 151
has
been mailed as constituting a failure of an applicant to engage in reasonable efforts to
conclude processing or examination of an application, in which case the period of
adjustment set forth in
37 CFR 1.703
shall be reduced by the
number of days, if any, beginning on the day after the date of mailing of the notice of
allowance under
35
U.S.C. 151
and ending on the date the request for continued
examination under
35
U.S.C. 132(b)
was filed. See
MPEP § 2732
for more
information.
Effective for applications in which a notice of allowance
was mailed on or after July 16, 2020,
37 CFR 1.704(c)(2), (c)(3), (c)(4), (c)(6), (c)(9), and
(c)(10)
were amended in the final rule
Patent Term
Adjustment Reductions in View of the Federal Circuit Decision in Supernus Pharm.,
Inc. v. Iancu,
85 FR 36335 (June 16, 2020). These paragraphs, as amended,
were revised to state the period of reduction is equal to “the period from the beginning
to the end of the applicant’s failure to engage in reasonable efforts to conclude
prosecution” and that the reduction cannot exceed the period of time during which an
applicant failed to engage in reasonable efforts.
Supernus Pharm., Inc. v.
Iancu,
913 F.3d 1351, 1359, 129 USPQ2d 1240 (Fed. Cir. 2019). Specifically,
37 CFR
1.704(c)(2)
was amended to end the reduction for applicant delay
on the earlier of the date a request to terminate the deferral was filed or the date the
patent was issued
nd that the reduction cannot exceed the period of time during which an
applicant failed to engage in reasonable efforts.
Supernus Pharm., Inc. v.
Iancu,
913 F.3d 1351, 1359, 129 USPQ2d 1240 (Fed. Cir. 2019). Specifically,
37 CFR
1.704(c)(2)
was amended to end the reduction for applicant delay
on the earlier of the date a request to terminate the deferral was filed or the date the
patent was issued.
37 CFR 1.704(c)(3)
was amended to
end the reduction for applicant delay on the date the grantable petition to revive the
application or accept late payment of the issue fee was filed.
37 CFR
1.704(c)(6)
was amended to begin the reduction for applicant delay
on the day after the date that is eight months from either the date on which the
application was filed under
35 U.S.C. 111(a)
or the date of
commencement of the national stage under
35 U.S.C. 371(b) or (f)
in an
international application and to end the reduction for applicant delay on the date the
preliminary amendment or other preliminary paper was filed.
37 CFR
1.704(c)(9)
was amended to begin the reduction for applicant delay
on the day after the date of the decision by the Patent Trial and Appeal Board or by a
Federal court and to end the reduction for applicant delay on date the amendment or
other paper was filed.
37 CFR 1.704(c)(10)
was amended to
begin the reduction for applicant delay on the day after the mailing date of the notice
of allowance under
35
U.S.C. 151
and to end the reduction for applicant delay on the
date the amendment under
37 CFR 1.312
or other paper was
filed.
37
CFR 1.704(c)(10)
was further amended to provide that if the
amendment under
37 CFR
1.312
or other paper expressly requested by the Office, such an
amendment or paper will not result in a reduction of patent term adjustment under
37 CFR
1.704(c)(10)
. If the amendment under
37 CFR 1.312
or
other paper was paper expressly requested by the Office, applicant will have three
months to file a reply without the filing resulting in an applicant delay under
37 CFR
1.704(b)
under
37 CFR
1.312
or other paper expressly requested by the Office, such an
amendment or paper will not result in a reduction of patent term adjustment under
37 CFR
1.704(c)(10)
. If the amendment under
37 CFR 1.312
or
other paper was paper expressly requested by the Office, applicant will have three
months to file a reply without the filing resulting in an applicant delay under
37 CFR
1.704(b)
.
The Office will decide any timely request for
reconsideration in compliance with
37 CFR 1.705(b)
of a patent term
adjustment determination in applications or patents eligible for patent term adjustment
in which a notice of allowance mailed prior to July 16, 2020, consistent with the
changes in the final rule discussed above, if requested by the patentee.
37 CFR 1.704(c)
was also amended to
change ‘‘mailing date’’ to ‘‘date of mailing’’ throughout for consistency with the other
regulations pertaining to AIPA patent term adjustment (
37 CFR
1.702
through
37 CFR 1.705
) and URAA patent term
extension (
37 CFR
1.701
). This conforming change was the only amendment to
37 CFR
1.704(c)(4)
. As background, the USPTO has been issuing Office
actions and notices through the Electronic Office Action Program since June of 2009 for
patent applicants choosing this form of notification. See
Electronic Office
Action,
1343 OG 45 (June 2, 2009). The term ‘‘date of mailing’’ as used in
the regulations pertaining to AIPA patent term adjustment and URAA patent term extension
means the mailroom/notification date indicated on the form PTOL–90 accompanying the
Office action or notice communication. See
Electronic Office Action,
1343 OG at 46 (‘‘The mailroom/notification date will also be considered the date of
mailing of the correspondence for all other purposes (e.g., 37 CFR 1.71(g)(2),1.97(b),
1.701 through 1.705).” ).
IV.
37 CFR 1.705 - DETERMINATION OF PATENT
TERM ADJUSTMENT
[Editor Note:
37 CFR
1.705
, as reproduced below, include amendments applicable only
to patents granted on or after January 14, 2013
ice Action,
1343 OG at 46 (‘‘The mailroom/notification date will also be considered the date of
mailing of the correspondence for all other purposes (e.g., 37 CFR 1.71(g)(2),1.97(b),
1.701 through 1.705).” ).
IV.
37 CFR 1.705 - DETERMINATION OF PATENT
TERM ADJUSTMENT
[Editor Note:
37 CFR
1.705
, as reproduced below, include amendments applicable only
to patents granted on or after January 14, 2013. See
37 CFR 1.705(a)-(f)
(pre-2013-04-01)
in effect with respect to applications
granted prior to January 14, 2013.]
37 CFR 1.705 Patent term adjustment determination
(a) The patent will include notification of any patent term
adjustment under
35 U.S.C. 154(b)
.
(b) Any request for reconsideration of the patent term adjustment
indicated on the patent must be by way of an application for patent term
adjustment filed no later than two months from the date the patent was granted.
This two-month period may be extended under the provisions of
§
1.136(a)
. An application for patent term adjustment under
this section must be accompanied by:
(1) The fee set forth in
§ 1.18(e)
; and
(2) A statement of the facts involved, specifying:
(i) The correct patent term adjustment and the basis
or bases under
§ 1.702
for the
adjustment;
(ii) The relevant dates as specified in
§§ 1.703(a) through
(e)
for which an adjustment is sought and the
adjustment as specified in
§ 1.703(f)
to
which the patent is entitled;
(iii) Whether the patent is subject to a terminal
disclaimer and any expiration date specified in the terminal
disclaimer; and
(iv)
(A) Any circumstances during the prosecution of
the application resulting in the patent that constitute a
failure to engage in reasonable efforts to conclude
processing or examination of such application as set forth in
§ 1.704
;
or
(B) That there were no circumstances
constituting a failure to engage in reasonable efforts to
conclude processing or examination of such application as set
forth in
§ 1.704
.
circumstances during the prosecution of
the application resulting in the patent that constitute a
failure to engage in reasonable efforts to conclude
processing or examination of such application as set forth in
§ 1.704
;
or
(B) That there were no circumstances
constituting a failure to engage in reasonable efforts to
conclude processing or examination of such application as set
forth in
§ 1.704
.
(c) Any requests for reinstatement of all or part of the period of
adjustment reduced pursuant to
§ 1.704(b)
for failing to
reply to a rejection, objection, argument, or other request within three months
of the date of mailing of the Office communication notifying the applicant of
the rejection, objection, argument, or other request be filed prior to the
issuance of the patent. This time period is not extendable. Any request for
reinstatement of all or part of the period of adjustment reduced pursuant to
§ 1.704(b)
must also be
accompanied by:
(1) The fee set forth in
§ 1.18(f)
; and
(2) A showing to the satisfaction of the Director that, in
spite of all due care, the applicant was unable to reply to the
rejection, objection, argument, or other request within three months of
the date of mailing of the Office communication notifying the applicant
of the rejection, objection, argument, or other request. The Office shall
not grant any request for reinstatement for more than three additional
months for each reply beyond three months from the date of mailing of the
Office communication notifying the applicant of the rejection, objection,
argument, or other request.
nths of
the date of mailing of the Office communication notifying the applicant
of the rejection, objection, argument, or other request. The Office shall
not grant any request for reinstatement for more than three additional
months for each reply beyond three months from the date of mailing of the
Office communication notifying the applicant of the rejection, objection,
argument, or other request.
(d) No submission or petition on behalf of a third party
concerning patent term adjustment under
35 U.S.C. 154(b)
will be
considered by the Office. Any such submission or petition will be returned to
the third party, or otherwise disposed of, at the convenience of the Office.
Section 1.705
implements the
provisions of
35
U.S.C. 154(b)(3) and (b)(4)(B)
. See
MPEP § 2733
for more
information on the patent term adjustment determination under
37 CFR
1.705(a)
and
MPEP § 2734
for more information on
requests for reconsideration under
37 CFR 1.705(b)
and the due care
showing under
37 CFR 1.705(c)
.
Any patent granted on or after January 14, 2013, is
subject to amended
37 CFR 1.705
.
[top]
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.